Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery

Blood Coagulation and Fibrinolysis

Volumn 12, Issue 3, 2001, Pages 215-216

  Biron Andreani C ^a   Dupeyron, G ^a   Mainemer, M ^a   Schved, J F ^a,b  

^a NÎMES UNIVERSITY HOSPITAL   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

Cataract; Haemophilia; Inhibitor; RFVIIa; Surgery

Indexed keywords

BLOOD CLOTTING FACTOR 8; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLEEDING; CASE REPORT; CATARACT EXTRACTION; DISEASE SEVERITY; HEMOPHILIA A; HEMOSTASIS; HUMAN; LOCAL ANESTHESIA; MALE; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; BLOOD LOSS, SURGICAL; CATARACT; CATARACT EXTRACTION; FACTOR VIIA; FACTOR VIII; HEMOPHILIA A; HEMOSTASIS, SURGICAL; HUMANS; ISOANTIBODIES; MALE; RECOMBINANT PROTEINS;

EID: 0034995691     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200104000-00009     Document Type: Article

References (6)

1. The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia A patient with inhibitor
2. Successful preoperative apheresis of factor VIII antibody using factor VIII concentrate as a replacement fluid
3. Major surgery in haemophilic patients with inhibitors using recombinant factor VIIa
4. Clinical experience with recombinant factor VIIa
5. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa
6. Optimal care of inhibitor patients during surgery